alendronate has been researched along with Cat Diseases in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Cat Diseases: Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-term treatment of cats with ionized hypercalcemia using alendronate has not been evaluated." | 9.20 | Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate. ( Braudaway, SR; Chew, DJ; de Brito Galvao, JF; DiBartola, SP; Green, TA; Hardy, BT; Lord, L, 2015) |
| "Describe clinical findings in a cohort of cats with persistent ionized hypercalcemia and evaluate long-term tolerance and efficacy of alendronate in these patients." | 8.12 | Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases. ( Benchekroun, G; Canonne-Guibert, M; Da Riz, F; Desquilbet, L; Kurtz, M; Maire, J; Maurey, C, 2022) |
| " In these formulations, alendronate oral bioavailability in cats was approximately 3%." | 5.35 | Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: a pilot proof-of-concept study. ( Feeney, WP; Halley, B; Harvey, CE; Hickey, G; Hill, SL; Jacks, TM; Miller, B; Mohn, KL; Schleim, KD, 2009) |
| "Long-term treatment of cats with ionized hypercalcemia using alendronate has not been evaluated." | 5.20 | Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate. ( Braudaway, SR; Chew, DJ; de Brito Galvao, JF; DiBartola, SP; Green, TA; Hardy, BT; Lord, L, 2015) |
| "Describe clinical findings in a cohort of cats with persistent ionized hypercalcemia and evaluate long-term tolerance and efficacy of alendronate in these patients." | 4.12 | Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases. ( Benchekroun, G; Canonne-Guibert, M; Da Riz, F; Desquilbet, L; Kurtz, M; Maire, J; Maurey, C, 2022) |
| " In these formulations, alendronate oral bioavailability in cats was approximately 3%." | 1.35 | Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: a pilot proof-of-concept study. ( Feeney, WP; Halley, B; Harvey, CE; Hickey, G; Hill, SL; Jacks, TM; Miller, B; Mohn, KL; Schleim, KD, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kurtz, M | 1 |
| Desquilbet, L | 1 |
| Maire, J | 1 |
| Da Riz, F | 1 |
| Canonne-Guibert, M | 1 |
| Benchekroun, G | 1 |
| Maurey, C | 1 |
| Larson, MJ | 1 |
| Oakes, AB | 1 |
| Epperson, E | 1 |
| Chew, DJ | 3 |
| Hardy, BT | 1 |
| de Brito Galvao, JF | 2 |
| Green, TA | 1 |
| Braudaway, SR | 1 |
| DiBartola, SP | 1 |
| Lord, L | 1 |
| Parker, V | 1 |
| Schenck, PA | 1 |
| Mohn, KL | 1 |
| Jacks, TM | 1 |
| Schleim, KD | 1 |
| Harvey, CE | 1 |
| Miller, B | 1 |
| Halley, B | 1 |
| Feeney, WP | 1 |
| Hill, SL | 1 |
| Hickey, G | 1 |
| Whitney, JL | 1 |
| Barrs, VR | 1 |
| Wilkinson, MR | 1 |
| Briscoe, KA | 1 |
| Beatty, JA | 1 |
1 review available for alendronate and Cat Diseases
| Article | Year |
|---|---|
Update on Feline Ionized Hypercalcemia.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Calcium; Cat Diseases; Cats; Diagnosis, Diff | 2017 |
1 trial available for alendronate and Cat Diseases
| Article | Year |
|---|---|
Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.
Topics: Administration, Oral; Alendronate; Animals; Calcium; Cat Diseases; Cats; Drug Administration Schedul | 2015 |
4 other studies available for alendronate and Cat Diseases
| Article | Year |
|---|---|
Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases.
Topics: Alendronate; Animals; Calcium; Cat Diseases; Cats; Cohort Studies; Hypercalcemia; Retrospective Stud | 2022 |
Medication-related osteonecrosis of the jaw after long-term bisphosphonate treatment in a cat.
Topics: Alendronate; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Cat Diseases; Cats; Diphos | 2019 |
Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: a pilot proof-of-concept study.
Topics: Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Cat Diseases; Cats; | 2009 |
Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Cat Diseases; Cats; Diphosphonates; Female; | 2011 |